Status:
COMPLETED
Does Preoperative Pain Medication Management Influence Surgical Outcomes in Spinal Fusion
Lead Sponsor:
Stanford University
Conditions:
Opioid Use
Spine Fusion
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In light of the current opioid epidemic, there is an urgent need to address chronic opioid use prior to surgery before it is exacerbated by postoperative surgical pain. Our central hypothesis is that ...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Indicated for lumbar, lumbosacral, or thoracolumbar spinal fusion surgery in the departments of Orthopedic Surgery and Neurosurgery
- Daily opioid use for at least 4 weeks prior to the preoperative planning appointment
Exclusion
- Suboxone (buprenorphine) use
- Unable to complete patient reported outcome measures (PROMs)
Key Trial Info
Start Date :
September 9 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04095624
Start Date
September 9 2019
End Date
July 1 2023
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Hospital and Clinics
Redwood City, California, United States, 94063